0
Sign In  | Subscribe
2 July 2002, Vol 137, No. 1>
Summaries for Patients | 2 July 2002

New Definitions for Healthy Ranges of Alanine Aminotransferase, a Blood Test of Liver Function FREE

[+] Article and Author Information

The summary below is from the full report titled “Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels.” It is in the 2 July 2002 issue of Annals of Internal Medicine (volume 137, pages 1-9). The authors are D Prati, E Taioli, A Zanella, E Della Torre, S Butelli, E Del Vecchio, L Vianello, F Zanuso, F Mozzi, S Milani, D Conte, M Colombo, and G Sirchia.


Ann Intern Med. 2002;137(1):I-37. doi:10.7326/0003-4819-137-1-200207020-00001
Text Size: A A A

What is the problem and what is known about it so far?

Alanine aminotransferase (ALT) is a blood test that doctors often use to evaluate patients for liver disease. High levels of ALT in a patient's blood suggest that he or she has liver disease. However, the test is not perfect. Many patients with liver disease have normal ALT levels. Infection with hepatitis C virus (HCV) and fatty deposits in the liver are two common reasons why people have abnormal ALT levels. The current “normal” ranges of ALT were defined before we knew about or could test for these conditions. As a result, some of the people considered “normal” (free of liver disease) when these ranges were established actually had HCV infection or fatty liver disease. The true normal values for ALT may be lower than the levels that laboratories currently consider normal. Knowing what ALT levels most accurately identify people with and without liver disease would be helpful.

Why did the researchers do this particular study?

To define new normal ranges for ALT among a group of people known not to have HCV infection or a fatty liver.

Who was studied?

6835 blood donors in Italy who had negative results on tests for HCV infection and 209 who were found to have HCV infection.

How was the study done?

The researchers measured ALT levels in all of the blood donors. They also collected information related to each person's risk for liver disease, including body size and other factors related to fatty liver. They then measured the ALT levels in patients who were unlikely to have liver disease, including HCV infection and fatty liver. Last, they applied these new ranges to the patients known to have HCV infection to see how many would have abnormal ALT levels according to the new definition of normal.

What did the researchers find?

The new upper limit of normal range for ALT (30 U/L for men and 19 U/L for women) were substantially lower than the levels that laboratories currently consider to be the upper range of normal (40 U/L for men and 30 U/L for women). Using these new definitions of normal, the researchers could more accurately identify the patients with HCV infection than they could using the old ranges.

What were the limitations of the study?

The researchers were unable to test whether the new ALT ranges could more accurately identify patients with fatty liver than the old ALT ranges.

What are the implications of the study?

Laboratories should consider revising the upper limits of normal for ALT to improve the accuracy of this test in identifying patients with liver disease.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

Topic Collections
PubMed Articles
The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study.
BMC complementary and alternative medicine Issue date: 2013
Effects of a new sustained-release microsphere formulation of exenatide, DA-3091, on obese and non-alcoholic fatty liver disease mice.
Die Pharmazie Issue date: 2013 Jan

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)